Azithromycin for COVID-19: Mechanistic Rationale and Evidence of Benefit

Authors: I. Giesselink, W. Janssens, P. Wergam, R. Vos Leuven University Clinic, BREATHE Research Group,

The effectiveness of azithromycin in solving diagnostic issues at the outpatient stage of managing patients with bronchopulmonary pathology

The use of azithromycin in the treatment of infectious diseases of the upper respiratory tract and ENT organs

Macrolides: Significance and Safety for the Treatment of Pneumonia